A detailed history of Brinker Capital Investments, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 10,693 shares of ILMN stock, worth $1.53 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,693
Previous 12,023 11.06%
Holding current value
$1.53 Million
Previous $2.29 Million 5.75%
% of portfolio
0.04%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$187.24 - $242.74 $249,029 - $322,844
-1,330 Reduced 11.06%
10,693 $2.16 Million
Q3 2022

Nov 01, 2022

SELL
$177.23 - $227.44 $151,177 - $194,006
-853 Reduced 6.62%
12,023 $2.29 Million
Q2 2022

Jul 18, 2022

SELL
$181.58 - $368.0 $4.5 Million - $9.12 Million
-24,779 Reduced 65.81%
12,876 $2.37 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $607,132 - $846,752
-1,998 Reduced 5.04%
37,655 $13.2 Million
Q4 2021

Feb 08, 2022

BUY
$347.28 - $421.83 $76,401 - $92,802
220 Added 0.56%
39,653 $15.1 Million
Q2 2021

Aug 03, 2021

BUY
$372.84 - $481.5 $3.34 Million - $4.31 Million
8,959 Added 29.4%
39,433 $18.7 Million
Q1 2021

May 12, 2021

BUY
$361.28 - $504.76 $3.51 Million - $4.91 Million
9,728 Added 46.89%
30,474 $11.7 Million
Q4 2020

Feb 16, 2021

SELL
$292.7 - $370.96 $5.02 Million - $6.37 Million
-17,161 Reduced 45.27%
20,746 $7.68 Million
Q3 2020

Dec 03, 2020

BUY
$268.51 - $400.74 $10.2 Million - $15.2 Million
37,907 New
37,907 $11.7 Million
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $50,198 - $61,481
-167 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $41,430 - $48,819
152 Added 1013.33%
167 $52,000
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $4,185 - $5,505
15 New
15 $6,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.